Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Cost of Revenue: 2019-2025

Historic Cost of Revenue for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to $14.6 million.

  • Eton Pharmaceuticals' Cost of Revenue rose 263.10% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 94.54%. This contributed to the annual value of $15.6 million for FY2024, which is 47.43% up from last year.
  • Eton Pharmaceuticals' Cost of Revenue amounted to $14.6 million in Q3 2025, which was up 108.51% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Cost of Revenue ranged from a high of $14.6 million in Q3 2025 and a low of $174,000 during Q2 2021.
  • Its 3-year average for Cost of Revenue is $4.4 million, with a median of $3.4 million in 2024.
  • Per our database at Business Quant, Eton Pharmaceuticals' Cost of Revenue soared by 1,477.59% in 2022 and then tumbled by 77.19% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Cost of Revenue (Quarterly) stood at $372,000 in 2021, then surged by 474.73% to $2.1 million in 2022, then surged by 72.26% to $3.7 million in 2023, then skyrocketed by 40.40% to $5.2 million in 2024, then surged by 263.10% to $14.6 million in 2025.
  • Its last three reported values are $14.6 million in Q3 2025, $7.0 million for Q2 2025, and $675,000 during Q1 2025.